Compared with recent advances in treatment of serious cardiovascular diseases, such as myocardial infarction and stroke, the treatment and outcome of acute pulmonary embolism (PE) have remained relatively unchanged over the last few decades. This has prompted several experts to call for the formation of multidisciplinary PE response teams with a more proactive approach to the treatment of PE. In the current document, we discuss the formation of such teams and describe the available treatment options beyond anticoagulation, with a focus on the interventional approach. Acknowledging the paucity of data to support widespread adoption of such techniques, we call for the collection of outcomes data in multicenter registries and support for randomized trials to evaluate interventional treatments in patients with high-risk PE. (J Am Coll Cardiol 2016;67:991-1002)
BUILDING AN ACUTE PE TEAM AND MANAGEMENT PATHWAY
Intensive management of acute PE begins with formation of a PERT. Assembling a team of specialists and coordinating care through a system similar to the management of ST-segment elevation myocardial infarction (STEMI) has been described at several institutions (3, 5, 6) . A PERT may consist of specialists from vascular medicine, pulmonary critical care, emergency medicine, interventional cardiology/ radiology, hematology, vascular surgery, and cardiothoracic surgery. Not every hospital system will engage all of these subspecialists, but we recommend, at a minimum, representatives from medicine, interventional cardiology/radiology, and surgery, as the decisions to be made require an understanding of the risks and benefits of all treatment modalities.
The PERT's responsibility is to assess each case in a timely manner, examine the patient, review the available data, perform any additional testing, and then (in conjunction with the patient, family members, and care team) develop a consensus regarding the optimal treatment plan. In certain patients with massive PE and rapid deterioration, the decision to
give fibrinolytic agents, go to the interventional laboratory, or proceed to the operating room will need to be made urgently by a limited number of PERT Importantly, subanalyses of patients younger than 65 years of age were performed post hoc in the trials included in the meta-analysis.
Taken together, these studies show that the use of IV fibrinolytic therapy in patients with massive or submassive PE leads to improved hemodynamic stabilization and, possibly, a lower risk of recurrent PE and PE-attributed death. However, this benefit comes with an increased risk of severe bleeding and intracranial hemorrhage (14) .
CATHETER-BASED THERAPIES
Catheter-based therapies aim to relieve obstruction quickly and restore pulmonary blood flow, thus improving cardiac output and converting a hemodynamically unstable situation into a stable one. This is accomplished with reduced or no doses of fibrino- PERT consult *Simplified pulmonary embolism severity index (sPESI) score ¼ 1 point for age >80 years, cancer, chronic heart failure or chronic pulmonary disease, heart rate >110 beats/min, SBP <100 mm Hg, or O 2 saturation <90%. Adapted with permission from Bloomer et al. (6) . Echo ¼ echocardiography; ER ¼ emergency room; IV ¼ intravenous; PE ¼ pulmonary embolism; PERT ¼ pulmonary embolism response team;
RV ¼ right ventricular; SBP = systolic blood pressure.
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Pulmonary Embolism M A R C H 1 , 2 0 1 6 : 9 9 1 -1 0 0 2 acute PE, giving advanced therapies a limited recommendation because of a lack of randomized control data (1,7).
Multiple percutaneous techniques have been described for treatment of unstable patients with PE (Table 1) . They aim at relieving the obstruction in the pulmonary circulation, thus immediately improving the patient's hemodynamics and potentially reducing the long-term risk of pulmonary hypertension (17) .
These techniques have been poorly studied, and they The FlowTriever device is advanced over the wire and into the thrombus, where the expandable disks are deployed using a pin and pull method. The disks and disrupted thrombus are then retracted and removed through the aspiration catheter. Set-up is rapid, and there is a modest learning curve for device utilization.
Limitations include the large size requirement of the access sheath, and manipulation of the large-bore catheter into the PA.
P e n u m b r a I n d i g o t h r o m b e c t o m y s y s t e m . The
Indigo mechanical thrombectomy system (Penumbra, Inc., Alameda, California) consists of a pump, 6-to 8-F straight or angled catheters, and a Separator device ( Figure 4) . It is approved for thrombus removal in both peripheral arterial and venous systems.
An advantage is that it only requires an 8-F venous A second infusion catheter may be placed in the 
SURGICAL EMBOLECTOMY
Currently, surgical therapy is considered a last resort for acute PE and is offered only to patients in extremis. This concept is on the basis of data from the 1960s, when the surgical pulmonary embolectomy mortality rate was in excess of 50% (34) . This may have been due, in part, to selection bias, as only patients with very poor prognosis were brought to the operating room. Significant advances in cardiac surgical techniques have led to an impressive reduction in operative mortality, which is as low as 6% in the current era (35, 36) . Furthermore, there is evidence to support reduced long-term mortality in patients undergoing pulmonary embolectomy (37, 38) . In a 2013 report on 27 consecutive surgical pulmonary embolectomy patients, there was no 
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